Sandbox : anmol: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 194: Line 194:
! colspan="1" rowspan="1" |Rash
! colspan="1" rowspan="1" |Rash
!Other symptoms
!Other symptoms
!Lab 1
!Immunochemistry
!Imaging 1
!Blood work
!Biopsy
!Biopsy
Histopathology
Histopathology
Line 269: Line 269:
|-
|-
| rowspan="6" |'''NEOPLASIA'''
| rowspan="6" |'''NEOPLASIA'''
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Hodgkin's disease  
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Hodgkin's disease<ref>{{cite book|title=Scientific Style and Format: The CBE Manual for Authors, Editors, and Publishers|url=https://books.google.com/books?id=PoFJ-OhE63UC&pg=PA97|year=1994|publisher=Cambridge University Press|isbn=978-0-521-47154-1|pages=97–}}</ref><ref name="Lozano_2012">{{cite journal  |vauthors=Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, etal | title = Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. | journal = Lancet | volume = 380 | issue = 9859 | pages = 2095–128 | date = Dec 15, 2012 | oclc = 23245604 | doi = 10.1016/S0140-6736(12)61728-0 }}</ref><ref name="pmid15164877">{{cite journal| author=Shishodia S, Aggarwal BB| title=Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer. | journal=Cancer Treat Res | year= 2004 | volume= 119 | issue=  | pages= 139-73 | pmid=15164877 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15164877  }}</ref><ref name="pmid8639794">{{cite journal| author=Bargou RC, Leng C, Krappmann D, Emmerich F, Mapara MY, Bommert K et al.| title=High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. | journal=Blood | year= 1996 | volume= 87 | issue= 10 | pages= 4340-7 | pmid=8639794 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8639794  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |painless
| style="background: #F5F5F5; padding: 5px;" |painless
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |  
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |<nowiki/>
**Lactate dehydrogenase (LDH) may be increased.
**ESR elevated
**Serum creatinine elevated in nephrotic syndrome.
**Alkaline phosphatase (ALP) increased
**Hypercalcemia, hypernatremia, and hypoglycemia.
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[ESR]]
* [[CRP]]<nowiki/>elevated
* [[ANA]] positive
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
 
| style="background: #F5F5F5; padding: 5px;" |[[Malar rash]] and [[photosensitivity]]
Fine-needle aspiration
*Mononucleate and binucleate Reed-Sternberg cells in a background of inflammatory cells
| style="background: #F5F5F5; padding: 5px;" |Reed-Sternberg cells on microscopic pathology.
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Chronic lymphocytic leukemia
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Chronic lymphocytic leukemia<ref name="pmid25461996">{{cite journal| author=Nabhan C, Rosen ST| title=Chronic lymphocytic leukemia: a clinical review. | journal=JAMA | year= 2014 | volume= 312 | issue= 21 | pages= 2265-76 | pmid=25461996 | doi=10.1001/jama.2014.14553 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25461996  }}</ref><ref name="pmid25908509">{{cite journal| author=Hallek M| title=Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment. | journal=Am J Hematol | year= 2015 | volume= 90 | issue= 5 | pages= 446-60 | pmid=25908509 | doi=10.1002/ajh.23979 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25908509  }}</ref><ref name="patho">Chronic Lymphocytic Leukemia. Libre Pathology (2015) http://librepathology.org/wiki/index.php/B_cell_small_lymphocytic_lymphoma/chronic_lymphocytic_leukemia Accessed on October, 12 2015</ref><ref name="pmid259085092">{{cite journal| author=Hallek M| title=Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment. | journal=Am J Hematol | year= 2015 | volume= 90 | issue= 5 | pages= 446-60 | pmid=25908509 | doi=10.1002/ajh.23979 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25908509  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |Painless
| style="background: #F5F5F5; padding: 5px;" |Painless
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Xerosis]]
*Recurrent [[bleeding]]
* Scaly skin
*[[Muscle wasting]]
* Annular [[erythema]]
*Generalized [[weakness]]
*Anorexia
*[[Abdominal pain]]
*Recurrent [[Infection|infections]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Monoclonality of kappa and lambda producing [[B cell|B cells]]
*Presence of smudge cells
*Express [[CD19]], [[CD20]], [[CD23]], and [[CD5]] on the [[cell]] surface
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
CBC
*Absolute [[lymphocytosis]] (>5000 cells/μl)
*Decreased [[hemoglobin]] concentration
*Decreased [[Platelet|platelets]] count
| style="background: #F5F5F5; padding: 5px;" |
*On [[microscopic]] [[histopathological]] analysis:
:*Small [[lymphoid]] [[cell]]s
:*Thin [[cytoplasmic]] border
:*Dense [[nucleus]]
:*Lack of [[nucleolus]]
:*Clumped [[chromatin]] aggregates
:*The presence of smudge cells
:*The presence of gumprecht [[nuclear]] shadows
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |[[Keratoconjunctivitis sicca]]
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Small cell carcinoma of the lung
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Small cell carcinoma of the lung<ref name="Zakowski2003">{{cite journal|last1=Zakowski|first1=Maureen F.|title=Pathology of small cell carcinoma of the lung|journal=Seminars in Oncology|volume=30|issue=1|year=2003|pages=3–8|issn=00937754|doi=10.1053/sonc.2003.50015}}</ref><ref name="NCI">National Cancer Institute: PDQ® Small Cell Lung Cancer Treatment. Bethesda, MD: National Cancer Institute.  Available at: http://www.cancer.gov/cancertopics/pdq/treatment/small-cell-lung/healthprofessional.</ref><ref>{{Cite journal
| author = [[Grace K. Dy]] & [[Alex A. Adjei]]
| title = Novel targets for lung cancer therapy: part I
| journal = [[Journal of clinical oncology : official journal of the American Society of Clinical Oncology]]
| volume = 20
| issue = 12
| pages = 2881–2894
| year = 2002
| month = June
| pmid = 12065566
}}</ref><ref>{{Cite journal
| author = [[K. Hibi]], [[T. Takahashi]], [[Y. Sekido]], [[R. Ueda]], [[T. Hida]], [[Y. Ariyoshi]], [[H. Takagi]] & [[T. Takahashi]]
| title = Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer
| journal = [[Oncogene]]
| volume = 6
| issue = 12
| pages = 2291–2296
| year = 1991
| month = December
| pmid = 1722571
}}</ref><ref>{{Cite journal
| author = [[Yuri Pekarsky]], [[Alexey Palamarchuk]], [[Kay Huebner]] & [[Carlo M. Croce]]
| title = FHIT as tumor suppressor: mechanisms and therapeutic opportunities
| journal = [[Cancer biology & therapy]]
| volume = 1
| issue = 3
| pages = 232–236
| year = 2002
| month = May-June
| pmid = 12432269
}}</ref>
| style="background: #F5F5F5; padding: 5px;" |painless
| style="background: #F5F5F5; padding: 5px;" |painless
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Syndrome of inappropriate antidiuresis]] ([[SIADH]])
* Hypercalcemia
*[[Cough]] (most common symptom)
*[[Wheezing]]
*[[Dyspnea]]
*[[Hemoptysis]]
*[[Chest pain]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Nearly all SCLC are immunoreactive for
*[[keratin]],
*[[thyroid transcription factor 1]],
*[[Epithelial cells|epithelial]] membrane [[antigen]]
[[Neuroendocrine]] and [[neural]] [[differentiation]] result in the expression of molecules like
*[[Dopamine beta-hydroxylase|dopa-decarboxylase]],
*[[calcitonin]]
*[[neuron-specific enolase]],
*[[chromogranin A]],
*[[CD56]]
*[[gastrin]]-releasing [[peptide]]
*[[insulin-like growth factor 1]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* The tumor cells are small and round, but they can sometimes be ovoid or spindle shaped. They have a scanty[[cytoplasm]] with a high mitotic count and a hyperchromatic [[nuclei]].
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Melanoma
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Melanoma<ref name="pmid16822996">{{cite journal| author=Miller AJ, Mihm MC| title=Melanoma. | journal=N Engl J Med | year= 2006 | volume= 355 | issue= 1 | pages= 51-65 | pmid=16822996 | doi=10.1056/NEJMra052166 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16822996  }}</ref><ref name="book1">{{cite book|last=Schanderdorf D, Kochs C, Livingstone E |date=2013 |title=Handbook of Cutaneous Melanoma: A Guide to Diagnosis and Treatment |publisher=Springer }}</ref><ref name="book2">{{cite book|last=Mooi W, Krausz T|date=2007 |title=Pathology of Melanocytic Disorders 2nd Ed. |publisher=CRC Press}}</ref>
| style="background: #F5F5F5; padding: 5px;" |painless
| style="background: #F5F5F5; padding: 5px;" |painless
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Rapid growth of an existing [[nevus]]
*[[Nevus|Bleeding nevus]]
*[[Nodule|Cutaneous nodules]]
*[[Hyperpigmentation|Hyper]]/[[Hypopigmented area|hypopigmented skin lesion]]
*[[Melanonychia]] (brown/blue nail discoloration)
*[[Skin ulcer|Non-healing skin ulcer]]
*[[Skin lesion|Painful skin lesion]]
*[[Pruritus]]
*[[Bone pain]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Positive for CD133+
* Positive for CD34+
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* An excisional biopsy (either elliptical, punch, or saucerization) of the thickest portion of the lesion with 1-3 mm margins.
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Epidermal atrophy and flattening and prominent dermal invasion
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lymphomatoid granulomatosis]]
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lymphomatoid granulomatosis]]
Line 328: Line 417:
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |+
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*[[Cough]]
*[[Cough]]
Line 344: Line 433:
*[[Nodule (medicine)|Subcutaneous nodules]]
*[[Nodule (medicine)|Subcutaneous nodules]]
*[[Nodule (medicine)|Larger ulcerated nodules]]
*[[Nodule (medicine)|Larger ulcerated nodules]]
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
'''CBC'''
'''CBC'''
*[[Leukopenia]]
*[[Leukopenia]]
Line 353: Line 441:
*[[Leukocytosis]] is rare
*[[Leukocytosis]] is rare
*Elevated [[Hematocrit]]
*Elevated [[Hematocrit]]
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |On chest CT scan, [[Halo sign]] is seen due to the angioinvasive nature of the disease
| style="background: #F5F5F5; padding: 5px;" |On chest CT scan, [[Halo sign]] is seen due to the angioinvasive nature of the disease
|-
|-
Line 361: Line 449:
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |+
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*[[Edema]]
*[[Edema]]
Line 393: Line 481:
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*[[Anemia]]
*[[Anemia]]
Line 402: Line 490:
*[[Fatigue]]
*[[Fatigue]]
*[[Weakness]]
*[[Weakness]]
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Complete blood count and differential count - [[low white blood cell counts]], which may to be due to the overproduction of [[interleukin 6]].
*Complete blood count and differential count - [[low white blood cell counts]], which may to be due to the overproduction of [[interleukin 6]].
*[[Erythrocyte sedimentation rate]] - elevated in 80% cases.
*[[Erythrocyte sedimentation rate]] - elevated in 80% cases.
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Hypersecretion of the cytokine [[Interleukin 6|IL-6]].
* Hypersecretion of the cytokine [[Interleukin 6|IL-6]].

Revision as of 02:18, 24 December 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]

Differential NHL

Diseases Clinical manifestations Para-clinical findings Pathogonomic finding
Symptoms
Lab Findings Biopsy

Histopathology

Lymphadenopathy Fever Weight loss Night Sweats Rash Other symptoms Immunochemistry Blood work
Non-Hodgkins lymphoma
  • painless
  • localized or generalized
+ + + +
  • Presents with "B" symptoms
INFECTIONS Bacteria Syphilis
  • painless
  • localized
+ - - + Primary syphilis:
  • Chancer

Secondary syphilis:

Tertiary syphilis

  • Gumma
  • Organ system involvement
  • Nontreponemal tests (e.g., VDRLand RPR )
  • Treponemal tests (e.g. FTA-ABS, the TP-PA assay
Painless clean base chancre.
Brucellosis
  • Painful
+ - - +
  • Abdominal pain
  • hepatosplenomegaly
  • arthritis
  • Brucella is most commonly isolated from blood cultures
Night sweats, often with characteristic smell, likened to wet hay
Viral infectious mononucleosis
  • painful
+ - - +
CMV + - - +
HIV
  • Painful or painless
- + - -
Cat scratch disease + - - +
Mycobacteria Tuberculosis
  • Painful
+ + + + Gohn's focus
Parasite Toxoplasmosis - -
Diseases Lymphadenopathy Fever Weight loss Night sweats Rash Other symptoms Immunochemistry Blood work Biopsy

Histopathology

Pathogonomical

findings

AUTOIMMUNE Systemic lupus erythematosus painless - - - + Malar rash and photosensitivity
Sjögren's syndrome Painless - - - + Keratoconjunctivitis sicca
Sarcoidosis painless - - - - -
Diseases Lymphadenopathy Fever Weight loss Night sweats Rash Other symptoms Immunochemistry Blood work Biopsy

Histopathology

Pathogonomical

findings

NEOPLASIA Hodgkin's disease[1][2][3][4] painless + + +
    • Lactate dehydrogenase (LDH) may be increased.
    • ESR elevated
    • Serum creatinine elevated in nephrotic syndrome.
    • Alkaline phosphatase (ALP) increased
    • Hypercalcemia, hypernatremia, and hypoglycemia.

Fine-needle aspiration

  • Mononucleate and binucleate Reed-Sternberg cells in a background of inflammatory cells
Reed-Sternberg cells on microscopic pathology.
Chronic lymphocytic leukemia[5][6][7][8] Painless + + + -
  • Monoclonality of kappa and lambda producing B cells
  • Presence of smudge cells

CBC

Small cell carcinoma of the lung[9][10][11][12][13] painless - - - -

Nearly all SCLC are immunoreactive for

Neuroendocrine and neural differentiation result in the expression of molecules like

  • The tumor cells are small and round, but they can sometimes be ovoid or spindle shaped. They have a scantycytoplasm with a high mitotic count and a hyperchromatic nuclei.
Melanoma[14][15][16] painless - - - -
  • Positive for CD133+
  • Positive for CD34+
  • An excisional biopsy (either elliptical, punch, or saucerization) of the thickest portion of the lesion with 1-3 mm margins.
Epidermal atrophy and flattening and prominent dermal invasion
Lymphomatoid granulomatosis painless + + - + -

CBC

- On chest CT scan, Halo sign is seen due to the angioinvasive nature of the disease
Angioimmunoblastic lymphadenopathy painless + + + +
  • Immunophenotyping
  • Fluorescence in situ hybridization (FISH)
Lymph node or extranodal tissue biopsy is diagnostic of angioimmunoblastic T-cell lymphoma.
  • Epstein–Barr virus (EBV) has been found in both reactive B-cells and the neoplastic T-cells.
  • Trisomy 3, trisomy 5, and +X are the most frequent chromosomal abnormalities found in cases.
NEOPLASIA Giant lymph node hyperplasia (Castleman disease) painless + + - - - -
  • Hypersecretion of the cytokine IL-6.

References

  1. Scientific Style and Format: The CBE Manual for Authors, Editors, and Publishers. Cambridge University Press. 1994. pp. 97–. ISBN 978-0-521-47154-1.
  2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. (Dec 15, 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet. 380 (9859): 2095–128. doi:10.1016/S0140-6736(12)61728-0. OCLC 23245604.
  3. Shishodia S, Aggarwal BB (2004). "Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer". Cancer Treat Res. 119: 139–73. PMID 15164877.
  4. Bargou RC, Leng C, Krappmann D, Emmerich F, Mapara MY, Bommert K; et al. (1996). "High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells". Blood. 87 (10): 4340–7. PMID 8639794.
  5. Nabhan C, Rosen ST (2014). "Chronic lymphocytic leukemia: a clinical review". JAMA. 312 (21): 2265–76. doi:10.1001/jama.2014.14553. PMID 25461996.
  6. Hallek M (2015). "Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment". Am J Hematol. 90 (5): 446–60. doi:10.1002/ajh.23979. PMID 25908509.
  7. Chronic Lymphocytic Leukemia. Libre Pathology (2015) http://librepathology.org/wiki/index.php/B_cell_small_lymphocytic_lymphoma/chronic_lymphocytic_leukemia Accessed on October, 12 2015
  8. Hallek M (2015). "Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment". Am J Hematol. 90 (5): 446–60. doi:10.1002/ajh.23979. PMID 25908509.
  9. Zakowski, Maureen F. (2003). "Pathology of small cell carcinoma of the lung". Seminars in Oncology. 30 (1): 3–8. doi:10.1053/sonc.2003.50015. ISSN 0093-7754.
  10. National Cancer Institute: PDQ® Small Cell Lung Cancer Treatment. Bethesda, MD: National Cancer Institute. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/small-cell-lung/healthprofessional.
  11. Grace K. Dy & Alex A. Adjei (2002). "Novel targets for lung cancer therapy: part I". Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20 (12): 2881–2894. PMID 12065566. Unknown parameter |month= ignored (help)
  12. K. Hibi, T. Takahashi, Y. Sekido, R. Ueda, T. Hida, Y. Ariyoshi, H. Takagi & T. Takahashi (1991). "Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer". Oncogene. 6 (12): 2291–2296. PMID 1722571. Unknown parameter |month= ignored (help)
  13. Yuri Pekarsky, Alexey Palamarchuk, Kay Huebner & Carlo M. Croce (2002). "FHIT as tumor suppressor: mechanisms and therapeutic opportunities". Cancer biology & therapy. 1 (3): 232–236. PMID 12432269. Unknown parameter |month= ignored (help)
  14. Miller AJ, Mihm MC (2006). "Melanoma". N Engl J Med. 355 (1): 51–65. doi:10.1056/NEJMra052166. PMID 16822996.
  15. Schanderdorf D, Kochs C, Livingstone E (2013). Handbook of Cutaneous Melanoma: A Guide to Diagnosis and Treatment. Springer.
  16. Mooi W, Krausz T (2007). Pathology of Melanocytic Disorders 2nd Ed. CRC Press.